Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2009-05-18 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VERNET (31810), Haute-Garonne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU LEVANT CORSINI : revenue, balance sheet and financial ratios
PHARMACIE DU LEVANT CORSINI is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VERNET (31810),
this company of category PME
shows in 2025 a net income positive of 399 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU LEVANT CORSINI (SIREN 513100750)
Indicator
2025
2024
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
399 174 €
292 010 €
221 836 €
104 938 €
77 870 €
-12 409 €
-16 221 €
-1 314 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DU LEVANT CORSINI generates positive net income of 399 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
399 174 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 37%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 55%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
37.024%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
54.564%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU LEVANT CORSINI
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2024
2025
Debt ratio
423.608
85.33
77.078
64.637
49.443
43.473
29.513
37.024
Financial autonomy
16.453
44.971
47.777
52.057
57.116
55.184
53.638
54.564
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
37.022025
2021
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good+10 pts over 3 years
In 2025, the debt ratio of PHARMACIE DU LEVANT CORSINI (37.02) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
54.56%2025
2021
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good-12 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DU LEVANT CORSINI (54.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 228.34. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
228.342
Liquidity indicators evolution PHARMACIE DU LEVANT CORSINI
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2024
2025
Liquidity ratio
139.579
209.522
211.427
240.022
255.273
208.44
181.129
228.342
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
228.342025
2021
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good+9 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DU LEVANT CORSINI (228.34) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DU LEVANT CORSINI in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DU LEVANT CORSINI is estimated at
6 340 926 €
(range 4 302 982€ - 9 949 786€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
4302k€6340k€9949k€
6 340 926 €Range: 4 302 982€ - 9 949 786€
NAF 5 année 2025
Valuation method used
Net Income Multiple
399 174 €
×
15.9x
=6 340 926 €
Range: 4 302 983€ - 9 949 787€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU LEVANT CORSINI with other companies in the same sector:
Frequently asked questions about PHARMACIE DU LEVANT CORSINI
What is the revenue of PHARMACIE DU LEVANT CORSINI ?
The revenue of PHARMACIE DU LEVANT CORSINI is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DU LEVANT CORSINI profitable?
Yes, PHARMACIE DU LEVANT CORSINI generated a net profit of 399 k€ in 2025.
Where is the headquarters of PHARMACIE DU LEVANT CORSINI ?
The headquarters of PHARMACIE DU LEVANT CORSINI is located in VERNET (31810), in the department Haute-Garonne.
Where to find the tax return of PHARMACIE DU LEVANT CORSINI ?
The tax return of PHARMACIE DU LEVANT CORSINI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU LEVANT CORSINI operate?
PHARMACIE DU LEVANT CORSINI operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart